Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

NCT00705107 · clinicaltrials.gov ↗

TERMINATED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C

Interventions

BIOLOGICAL: PegIntron pen (peginterferon alfa-2b; SCH 54031)
DRUG: Rebetol (ribavirin; SCH 18908)

Sponsor

Merck Sharp & Dohme LLC